{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:43:05Z","timestamp":1787024585512,"version":"build-2736575974"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.2169\/internalmedicine.1365-22","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:12:40Z","timestamp":1692036760000},"page":"2419-2425","source":"Crossref","is-referenced-by-count":5,"title":["Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review"],"prefix":"10.2169","volume":"62","author":[{"given":"Takafumi","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Shijo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensho","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Mitobe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Umezawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Misu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol 4422: 2-3, 2020.","DOI":"10.2139\/ssrn.3589350"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kubota T, Gajera PK, Kuroda N. Meta-analysis of EEG findings in patients with COVID-19. Epilepsy Behav 115: 107682, 2020.","DOI":"10.1016\/j.yebeh.2020.107682"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kubota T, Kuroda N. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: a systematic review. Clin Neurol Neurosurg 106349, 2020.","DOI":"10.1016\/j.clineuro.2020.106349"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci 43: 3-40, 2022.","DOI":"10.1007\/s10072-021-05662-9"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Kubota T, Hasegawa T, Ikeda K, Aoki M. Case report: isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination. F1000Research 10: 1142, 2021.","DOI":"10.12688\/f1000research.74299.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nagalli S, Shankar Kikkeri N. Sub-acute onset of Guillain-Barr\u00e9 syndrome post-mRNA-1273 vaccination: a case report. SN Compr Clin Med 4: 41, 2022.","DOI":"10.1007\/s42399-022-01124-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Suri V, Pandey S, Singh J, Jena A. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ Case Rep 14: 14-17, 2021.","DOI":"10.1136\/bcr-2021-245816"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bagella CF, Corda DG, Zara P, et al. Chronic inflammatory demyelinating polyneuropathy after ChAdOx1 nCoV-19 vaccination. Vaccines 9: 1502, 2021.","DOI":"10.3390\/vaccines9121502"},{"key":"9","unstructured":"9. Katada E, Toyoda T, Yamada G, Morishima A, Matsukawa N. A case of chronic inflammatory demyelinating polyneuropathy following COVID-19 vaccine. Neurol Clin Neurosci. Forthcoming."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Singh S, Sanna F, Adhikari R, Akella R, Gangu K. Chronic inflammatory demyelinating polyneuropathy post-mRNA-1273 vaccination. Cureus 14: e24528, 2022.","DOI":"10.7759\/cureus.24528"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. de Souza A, Oo WM, Giri P. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course. J Neurol Sci 436: 120231, 2022.","DOI":"10.1016\/j.jns.2022.120231"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibodypositive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82: 474-481, 2014.","DOI":"10.1212\/WNL.0000000000000101"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force - second revision. Eur J Neurol 28: 3556-3583, 2021.","DOI":"10.1111\/ene.14959"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mori K, Hattori N, Yamamoto M, Sobue G. Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology 59: 1824, 2002.","DOI":"10.1212\/WNL.59.11.1823-a"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Odaka M, Yuki N, Hirata K. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barr\u00e9 syndrome. J Neurol 250: 913-916, 2003.","DOI":"10.1007\/s00415-003-1096-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 114: 49-55, 1993.","DOI":"10.1016\/0022-510X(93)90048-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Abolmaali M, Rezania F, Behnagh AK, Hamidabad NM, Gorji A, Mirzaasgari Z. Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review. Immunol Res 1: 1, 2022.","DOI":"10.21203\/rs.3.rs-1821109\/v1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand? Clin Rheumatol 41: 1603, 2022.","DOI":"10.1007\/s10067-022-06149-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Koike H, Chiba A, Katsuno M. Emerging infection, vaccination, and Guillain-Barr\u00e9 syndrome: a review. Neurol Ther 10: 523-537, 2021.","DOI":"10.1007\/s40120-021-00261-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ludwig H, Sonneveld P, Facon T, et al. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Hematol 8: e934-e946, 2021.","DOI":"10.1016\/S2352-3026(21)00278-7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fasanya AA, Loncharich MF, Gandhi V, Rana S, Balaan M. Multiple myeloma associated chronic inflammatory demyelinating polyradiculoneuropathy: the importance of continued surveillance. Cureus 8: e899, 2016.","DOI":"10.7759\/cureus.899"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Xu YL, Zhao WH, Tang ZY, et al. Guillain-Barr\u00e9 syndrome in a patient with multiple myeloma after bortezomib therapy: a case report. World J Clin Cases 7: 2905-2909, 2019.","DOI":"10.12998\/wjcc.v7.i18.2905"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zhang L, Arrington S, Keung YK. Guillain-Barr\u00e9 syndrome after transplantation. Leuk Lymphoma 49: 291-297, 2008.","DOI":"10.1080\/10428190701760003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 7: 507-517, 2011.","DOI":"10.1038\/nrneurol.2011.121"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Doneddu PE, Bianchi E, Cocito D, et al. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. Eur J Neurol 27: 136-143, 2020.","DOI":"10.1111\/ene.14044"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matteo E, Romoli M, Calabr\u00f2 C, et al. Combined central and peripheral demyelination with anti-neurofascin155 IgG following COVID-19 vaccination. Can J Neurol Sci 50: 141-143, 2021.","DOI":"10.1017\/cjn.2021.256"},{"key":"27","unstructured":"27. Ogata H, Matsuse D, Yamasaki R, et al. A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry 87: 29-36, 2016."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Huang Y, Ling Q, Manyande A, Wu D, Xiang B. Brain imaging changes in patients recovered from COVID-19: a narrative review. Front Neurosci 16: 1-12, 2022.","DOI":"10.3389\/fnins.2022.855868"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hanafi R, Roger P-A, Perin B, et al. COVID-19 neurologic complication with CNS vasculitis-like pattern. AJNR Am J Neuroradiol 41: 1384-1387, 2020.","DOI":"10.3174\/ajnr.A6651"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hopkins RO, Beck CJ, Burnett DL, Weaver LK, Victoroff J, Bigler ED. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging 16: 243-251, 2006.","DOI":"10.1111\/j.1552-6569.2006.00047.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly individuals. Biol Psychiatry 64: 273, 2008.","DOI":"10.1016\/j.biopsych.2008.03.024"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fassas ABT, Muwalla F, Berryman T, et al. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations. Br J Hematol 117: 103-108, 2002.","DOI":"10.1046\/j.1365-2141.2002.03401.x"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Iijima M, Yamamoto M, Hirayama M, et al. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 64: 1471-1475, 2005.","DOI":"10.1212\/01.WNL.0000158680.89323.F8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_1365-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T23:22:26Z","timestamp":1692400946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/16\/62_1365-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":33,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1365-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"1365-22"}}